Danaher Co. (NYSE:DHR) Shares Sold by Axxcess Wealth Management LLC

Axxcess Wealth Management LLC decreased its position in Danaher Co. (NYSE:DHR) by 9.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,901 shares of the conglomerate’s stock after selling 1,308 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Danaher were worth $2,732,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Heck Capital Advisors LLC acquired a new position in Danaher in the 4th quarter worth $27,000. Decker Retirement Planning Inc. purchased a new stake in shares of Danaher during the fourth quarter worth about $31,000. Golden State Wealth Management LLC acquired a new position in shares of Danaher in the fourth quarter worth about $31,000. Strategic Financial Concepts LLC purchased a new position in Danaher in the fourth quarter valued at about $31,000. Finally, Pineridge Advisors LLC grew its stake in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.1 %

DHR opened at $212.71 on Wednesday. The stock’s 50 day moving average price is $219.04 and its 200 day moving average price is $239.67. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The stock has a market cap of $152.03 billion, a P/E ratio of 40.29, a P/E/G ratio of 2.66 and a beta of 0.82. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the business earned $2.09 EPS. As a group, research analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.32 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s dividend payout ratio is currently 24.24%.

Analysts Set New Price Targets

DHR has been the subject of several research analyst reports. Stifel Nicolaus upgraded Danaher from a “hold” rating to a “buy” rating and set a $260.00 target price for the company in a research note on Friday, March 14th. Royal Bank of Canada reiterated an “outperform” rating and set a $277.00 price objective (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Wells Fargo & Company dropped their target price on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research report on Thursday, January 30th. Robert W. Baird reduced their price target on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, The Goldman Sachs Group set a $250.00 price objective on Danaher in a report on Wednesday, January 15th. Six analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $277.76.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 10.90% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.